Reet International

Zunestar Tablet contains Eszopiclone 3 mg, a sedative-hypnotic medication used primarily for the treatment of insomnia. Eszopiclone helps individuals fall asleep faster, stay asleep longer, and reduce the number of awakenings during the night, promoting better sleep quality. It works by affecting neurotransmitters in the brain, specifically increasing the activity of gamma-aminobutyric acid (GABA), a chemical that induces relaxation and sedation.
Zunestar is typically taken right before bedtime, with the dosage and duration of treatment depending on the severity of the patient’s insomnia and response to the medication. It is important not to take the tablet unless the patient can dedicate a full 7-8 hours to sleep, as taking it without sufficient sleep time may result in drowsiness or impaired alertness the next day.
Common side effects of Eszopiclone include dizziness, headache, dry mouth, and a bitter taste. Some individuals may experience more serious side effects such as memory problems, sleepwalking, or unusual behaviors while not fully awake, such as eating, driving, or making phone calls. If any such behaviors occur, it is important to contact a healthcare provider.
Eszopiclone may cause physical or psychological dependence if used for a prolonged period, so it is generally prescribed for short-term use. It is crucial to follow the doctor's prescription and avoid suddenly stopping the medication, as this can lead to withdrawal symptoms like anxiety, sweating, or shaking.
Zunestar should be used with caution in patients with liver problems, respiratory conditions, or a history of substance abuse. Alcohol should be avoided while taking Eszopiclone, as it can enhance the sedative effects and lead to dangerous side effects.
Overall, Zunestar 3 mg is an effective treatment for short-term insomnia, helping individuals achieve better sleep quality. However, its use should be closely monitored to avoid potential dependency or adverse effects.